© 2024 澳门正规博彩十大排行平台. All rights reserved.


Dr. Vedantham joined 澳门正规博彩十大排行平台 in 2021. He is a seasoned leader in the biopharmaceutical industry, with global experience in various chemistry, manufacturing, and controls (CMC) functions across R&D and Technical Operations. He brings a strong scientific background; breadth and depth in many different aspects of technical development; experience in leading technical operation groups in the strategic development, production, and distribution of diverse and complex biological products on a worldwide basis; and a strong quality and regulatory foundation that build on 澳门正规博彩十大排行平台’s outstanding compliance record. Previously, Dr. Vedantham spent more than two decades at Amgen/Immunex in increasingly senior roles across the organization. He is known for demonstrating strategic vision, the ability to build and lead diverse and high-performing teams, and encouraging open, collaborative, supportive, and driven cultures. Dr. Vedantham earned a Ph.D. in chemical engineering from Carnegie Mellon University, a M.S. in chemical engineering from Rensselaer Polytechnic Institute, and a B.Tech in chemical engineering from the Indian Institute of Technology, Kharagpur.


Our Pipeline

We maximize the impact of genetic innovation to develop transformative therapies.

Each drug candidate we pursue is guided by a fundamental understanding of the genetics and underlying biology of the condition it will address.

Learn More Our Pipeline